VFEND 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
VFEND 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Commercialized
Register Number
02212005
Prescription Type
Uso Hospitalario
Authorization Date
May 6, 2002
Dosage Form
COMPRIMIDO RECUBIERTO
Route: VÍA ORAL
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number02212005
EMA Approved
Yes
Drug Classification
✗
Generic
No
✗
Orphan
No
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
VORICONAZOLActive
Quantity: 50 mg
Name: VORICONAZOL
ATC CLASSIFICATION (3)
J02A
J02AC
J02AC03